Safety and tolerability of vorinostat - Experience from the vorinostat clinical trial program

被引：0
|
作者：
Siegel, D. [1 ]
Hussein, M. [2 ]
Belani, C. P. [3 ]
Robert, F. [4 ]
Rizvi, S.
Wigginton, J.
Randolph, S.
Ricker, J. L.
Lis, J.
Garcia-Vargas, J.
Sanz-Rodriguez, C. [5 ]
机构：
[1] Hackensack Univ, Med Ctr, Myeloma Canc Ctr, Hackensack, NJ USA
[2] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Interdisciplinary Oncol, Tampa, FL 33682 USA
[3] Penn State Coll Med, Penn State Canc Inst, Hershey, PA USA
[4] Univ Alabama, Ctr Comprehens Canc, Birmingham, AL 35294 USA
[5] Merck & Co Inc, Merck Sharp & Dohme, Madrid, Spain
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：162 / 162
页数：1
相关论文
共 50 条
  • [1] SAFETY AND TOLERABILITY OF VORINOSTAT - EXPERIENCE FROM THE VORINOSTAT CLINICAL TRIAL PROGRAM
    Siegel, D.
    Hussein, M.
    Belani, C. P.
    Robert, F.
    Rizvi, S.
    Wigginton, J.
    Randolph, S.
    Ricker, J. L.
    Lis, J.
    Garcia-Vargas, J.
    Sanz-Rodriguez, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 114 - 114
  • [2] Safety and tolerability of vorinostat-Experience from the vorinostat clinical trial program
    Siegel, D. S.
    Hussein, M. A.
    Belani, C. P.
    Robert, F.
    Rizvi, S.
    Wigginton, J.
    Randolph, S.
    Crane, R.
    Ganesan, R.
    Garcia-Vargas, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] Clinical experience with vorinostat: collated safety and tolerability data from patients with solid or hematologic malignancies
    Siegel, D.
    Munster, P. N.
    Iwamoto, M.
    van Belle, S.
    Hussein, M.
    Belani, C.
    Robert, F.
    Galanis, E.
    Rizvi, S.
    Rubin, E. H.
    EJC SUPPLEMENTS, 2009, 7 (02): : 570 - 570
  • [4] The Safety and Tolerability of Vorinostat in Combination with Lapatinib in Advanced Solid Tumors
    Chumsri, S.
    Tait, N. S.
    Medeiros, M. M.
    Bauer, K. S.
    Betts, K-M T.
    Lewis, J. C.
    Bao, T.
    Feigenberg, S. J.
    Kesmodei, S. B.
    Stearns, V.
    Edelman, M. J.
    Sausville, E. A.
    Tkaczuk, K. H. R.
    CANCER RESEARCH, 2011, 71
  • [5] Clinical efficacy and safety of vorinostat in relapsed/refractory CTCL
    Olsen, E. A.
    Duvic, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 156 - 156
  • [6] Vorinostat as a radiosensitizer for brain metastasis: a phase I clinical trial
    Shi, Wenyin
    Lawrence, Yaacov Richard
    Choy, Hak
    Werner-Wasik, Maria
    Andrews, David W.
    Evans, James J.
    Judy, Kevin D.
    Farrell, Christopher J.
    Moshel, Yaron
    Berger, Adam C.
    Bar-Ad, Voichita
    Dicker, Adam P.
    JOURNAL OF NEURO-ONCOLOGY, 2014, 118 (02) : 313 - 319
  • [7] Vorinostat as a radiosensitizer for brain metastasis: a phase I clinical trial
    Wenyin Shi
    Yaacov Richard Lawrence
    Hak Choy
    Maria Werner-Wasik
    David W. Andrews
    James J. Evans
    Kevin D. Judy
    Christopher J. Farrell
    Yaron Moshel
    Adam C. Berger
    Voichita Bar-Ad
    Adam P. Dicker
    Journal of Neuro-Oncology, 2014, 118 : 313 - 319
  • [8] Safety and Tolerability of Conatumumab in Combination with Bortezomib or Vorinostat in Patients with Relapsed or Refractory Lymphoma.
    Younes, Anas
    Kirschbaum, Mark
    Sokol, Lubomir
    Yee, Lorrin
    Romaguera, Jorge
    Goyal, Lovely
    Hsu, Cheng-Pang
    Hwang, Yuying
    Gorski, Kevin
    Wong, Susan
    Beaupre, Darrin M.
    BLOOD, 2009, 114 (22) : 680 - 681
  • [9] vorinostat-based therapy for solidor hematologic malignancies: The combined safety and tolerability profile.
    Siegel, D. S.
    Rubin, E. H.
    VanBelle, S.
    Hussein, M. A.
    Belani, C. P.
    Robert, F.
    Galanis, E.
    Boileau, K. T.
    Eid, J. E.
    Graef, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [10] The Combined Safety and Tolerability Profile of Vorinostat-Based Therapy for Solid or Hematologic Malignancies.
    Siegel, David
    Munster, Pamela N.
    Rubin, Eric
    Iwamoto, Marian
    van Belle, Simon
    Hussein, Mohamad
    Belani, Chandra P.
    Robert, Francisco
    Galanis, Evanthia
    Hardwick, James
    Rizvi, Syed
    BLOOD, 2009, 114 (22) : 681 - 682
12345